BURLINGTON, Mass., Feb. 23, 2012 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO), a biopharmaceutical company focused on the development of novel immunotherapy agents for the treatment of autoimmune diseases and cancer, today announced that Dr. Bobby W. Sandage, Jr., Coronado’s President and CEO, will present at the at the Citi 2012 Global Health Care Conference on Wednesday, February 29, 2012, at 8:00 AM ET. The conference will be held at the Waldorf Astoria Hotel in New York City.
